NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
Back to search
Official data from USPTO
A
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
09/26/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
04/24/2018
Registration date
09/26/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
09/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/05/2021
First use in commerce
01/05/2021
Drawing code
3
Owner type
03
Owner location
Long Beach, CA, US
Examiner
O'BRIEN, JENNIFER
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a dotted "A".
Holders and representatives
Holders
Anivive Lifesciences, Inc
Representatives
Ian W. Gillies KNOBBE MARTENS OLSON & BEAR LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutraceuticals for the purpose of treating animal diseasesanimal conditions and animal illnesses in the field of veterinary medicine in the nature of autoimmune disordersoncologic disordersrenal and urinary tract disordersneurologic disordersmusculoskeletal disordersinfectious disease disordersdermatologic disordersophthalmic disorderscardiovascular disordersrespiratory disordersendocrine disordersmetabolic disorders including obesitygastrointestinal disorders; Pharmaceuticalspharmaceuticals for the purpose of treating animal diseasesanimal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disordersoncologic disordersrenal and urinary tract disordersneurologic disordersmusculoskeletal disordersinfectious disease disordersdermatologic disordersophthalmic disorderscardiovascular disordersrespiratory disordersendocrine disordersmetabolic disorders including obesitygastrointestinal disorders; Vaccines in the field of veterinary medicine; Therapeutic pharmaceuticals for the purpose of treating animal diseasesanimal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disordersoncologic disordersrenal and urinary tract disordersneurologic disordersmusculoskeletal disordersinfectious disease disordersdermatologic disordersophthalmic disorderscardiovascular disordersrespiratory disordersendocrine disordersmetabolic disorders including obesitygastrointestinal disorders
Class 42
Drug discovery services for veterinary medicine; providing pharmaceutical and medical research services and clinicalmedical and scientific research information in the field of animal health; analysis services for veterinary medicineclinicalmedical and scientific research; obtainingrecordinganalyzingreporting and modeling data for animal health purposeselectronic monitoring and reporting of clinical informationagesexbreedneuter statusbody weightbody condition scoreblood pressureheart ratefrequency and character of respirationappetitepresence or absence of vomitingactivity levelfood and water intakefrequency and character of urination and defecationof animalsusing computers or sensors; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for use in database managementfor use as a spreadsheetfor word processingfor statistical analysisdata aggregationdata processingreport generationdata sharingremote data managementremote project managementdata analysis in the field of veterinary medicine for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for assisting in drug discovery in the nature of managing clinical trials for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software to facilitate ordering and delivery of medications and treatment to animal ownersdistributors and veterinary health care providers for animal health purposes
Publications
History of USPTO decisions and trademark events.
65 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/23/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/22/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/31/2023
IUAF
USE AMENDMENT FILED
07/14/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/14/2023
DOCK
ASSIGNED TO EXAMINER
03/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/03/2023
EX5G
SOU EXTENSION 5 GRANTED
02/02/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/26/2023
EXT5
SOU EXTENSION 5 FILED
01/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2022
EX4G
SOU EXTENSION 4 GRANTED
06/17/2022
EXT4
SOU EXTENSION 4 FILED
06/17/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2022
EX3G
SOU EXTENSION 3 GRANTED
01/07/2022
EXT3
SOU EXTENSION 3 FILED
01/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2021
EX2G
SOU EXTENSION 2 GRANTED
07/01/2021
EXT2
SOU EXTENSION 2 FILED
07/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2021
EX1G
SOU EXTENSION 1 GRANTED
01/07/2021
EXT1
SOU EXTENSION 1 FILED
01/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2020
PUBO
PUBLISHED FOR OPPOSITION
05/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2020
EXPT
EXPARTE APPEAL TERMINATED
04/13/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2020
ALIE
ASSIGNED TO LIE
03/31/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/23/2020
EXPI
EX PARTE APPEAL-INSTITUTED
03/23/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/23/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/23/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/25/2019
GNFR
FINAL REFUSAL E-MAILED
09/25/2019
CNFR
FINAL REFUSAL WRITTEN
09/25/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/26/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/04/2019
GNRT
NON-FINAL ACTION E-MAILED
03/04/2019
CNRT
NON-FINAL ACTION WRITTEN
03/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/16/2018
GPRA
PRIORITY ACTION E-MAILED
08/16/2018
CPRA
PRIORITY ACTION WRITTEN
08/16/2018
DOCK
ASSIGNED TO EXAMINER
08/14/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2018
NWAP
NEW APPLICATION ENTERED
04/27/2018
Continuous trademark protection
Get notified about every new filing that threatens A or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.